Mass: 8940.293 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: UUCG-TAR RNA / Source: (gene. exp.) Human immunodeficiency virus 2 / Plasmid: puc19 / Production host: Escherichia coli (E. coli)
#2: Polypeptide(D)
Pyrimidinylpeptide
Mass: 507.613 Da / Num. of mol.: 2 / Source method: obtained synthetically / Details: Synthetic peptide
-
Experimental details
-
Experiment
Experiment
Method: SOLUTION NMR Details: High resolution NMR solution structure of a complex of HIV-2 TAR RNA and a synthetic tripeptide in a 1:2 stoichiometry
NMR experiment
Conditions-ID
Experiment-ID
Solution-ID
Type
2
1
1
2D 1H-15N HSQC
1
2
2
2D 1H-13C HSQC
1
3
3
2D 1H-1H TOCSY
1
4
3
2D 1H-1H NOESY
1
5
4
2D 1H-1H NOESY
1
6
2
3D (H)CCH-TOCSY
1
7
2
3D (H)CCH-COSY
2
8
1
3D 1H-15N NOESY
1
9
2
3D 1H-13C NOESY
1
10
2
2DH(C)N
1
11
2
2D 1H-15N HSQC (2J)
1
12
2
2D 1H-13C HSQC
2
13
1
2D HNN-COSY
1
14
2
2D H5NN-COSY
1
15
2
3D forward-directed HCC-TOCSY-CCH E.COSY
2
16
1
2D 1H-15N CPMG-NOESY
-
Sample preparation
Details
Solution-ID
Contents
Solvent system
1
0.65 mM [U-100% 13C; U-100% 15N] UUCG-TAR-1, 5.2 mM Pyrimidinylpeptide-2, 50 mM potassium chloride-3, 25 mM potassium phosphate-4, 90% H2O/10% D2O
90% H2O/10% D2O
2
0.65 mM [U-100% 13C; U-100% 15N] UUCG-TAR-5, 5.2 mM Pyrimidinylpeptide-6, 50 mM potassium chloride-7, 25 mM potassium phosphate-8, 100% D2O
100% D2O
3
0.65 mM UUCG-TAR-9, 5.2 mM Pyrimidinylpeptide-10, 50 mM potassium chloride-11, 25 mM potassium phosphate-12, 90% H2O / 10% D2O
90% H2O/10% D2O
4
0.65 mM UUCG-TAR-13, 5.2 mM Pyrimidinylpeptide-14, 50 mM potassium chloride-15, 25 mM potassium phosphate-16, 100% D2O
100% D2O
5
0.2 mM [U-100% 13C; U-100% 15N] UUCG-TAR-17, 0.8 mM Pyrimidinylpeptide-18, 50 mM potassium chloride-19, 25 mM potassium phosphate-20, 16 mg/mL Pf1 phage-21, 100% D2O
100% D2O
Sample
Conc. (mg/ml)
Component
Isotopic labeling
Solution-ID
0.65mM
UUCG-TAR-1
[U-100% 13C; U-100% 15N]
1
5.2mM
Pyrimidinylpeptide-2
1
50mM
potassium chloride-3
1
25mM
potassium phosphate-4
1
0.65mM
UUCG-TAR-5
[U-100% 13C; U-100% 15N]
2
5.2mM
Pyrimidinylpeptide-6
2
50mM
potassium chloride-7
2
25mM
potassium phosphate-8
2
0.65mM
UUCG-TAR-9
3
5.2mM
Pyrimidinylpeptide-10
3
50mM
potassium chloride-11
3
25mM
potassium phosphate-12
3
0.65mM
UUCG-TAR-13
4
5.2mM
Pyrimidinylpeptide-14
4
50mM
potassium chloride-15
4
25mM
potassium phosphate-16
4
0.2mM
UUCG-TAR-17
[U-100% 13C; U-100% 15N]
5
0.8mM
Pyrimidinylpeptide-18
5
50mM
potassium chloride-19
5
25mM
potassium phosphate-20
5
16mg/mL
Pf1 phage-21
5
Sample conditions
Conditions-ID
Ionic strength
pH
Pressure (kPa)
Temperature (K)
1
75
6.2
ambient
298K
2
75
6.2
ambient
283K
-
NMR measurement
NMR spectrometer
Type
Manufacturer
Model
Field strength (MHz)
Spectrometer-ID
Bruker Avance
Bruker
AVANCE
900
1
Bruker Avance
Bruker
AVANCE
800
2
Bruker Avance
Bruker
AVANCE
700
3
Bruker Avance
Bruker
AVANCE
600
4
Bruker DRX
Bruker
DRX
600
5
Bruker Avance
Bruker
AVANCE
400
6
-
Processing
NMR software
Name
Version
Developer
Classification
TopSpin
2.1
BrukerBiospin
collection
TopSpin
2.1
BrukerBiospin
processing
TopSpin
2.1
BrukerBiospin
dataanalysis
Sparky
3.114
Goddard
chemicalshiftassignment
Sparky
3.114
Goddard
dataanalysis
Sparky
3.114
Goddard
peakpicking
CNS
1.1
Brunger, Adams, Clore, Gros, NilgesandRead
structuresolution
ARIA
1.2
Linge, O'DonoghueandNilges
refinement
HADDOCK
2.1
Dominguez, BoelensandBonvin
refinement
Refinement
Method: simulated annealing / Software ordinal: 1
NMR constraints
NA alpha-angle constraints total count: 22 / NA beta-angle constraints total count: 4 / NA chi-angle constraints total count: 27 / NA epsilon-angle constraints total count: 5 / NA other-angle constraints total count: 22 / NA sugar pucker constraints total count: 95 / NOE constraints total: 567 / Hydrogen bond constraints total count: 60
NMR representative
Selection criteria: top-ranked ensemble
NMR ensemble
Conformer selection criteria: Top-ranked ensemble / Conformers calculated total number: 200 / Conformers submitted total number: 10
+
About Yorodumi
-
News
-
Feb 9, 2022. New format data for meta-information of EMDB entries
New format data for meta-information of EMDB entries
Version 3 of the EMDB header file is now the official format.
The previous official version 1.9 will be removed from the archive.
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi